Product References
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy.
Scientific reports
Al Shboul S,El-Sadoni M,Alhesa A,Abu Shahin N,Abuquteish D,Abu Al Karsaneh O,Alsharaiah E,Ismail MA,Tyutyunyk-Massey L,Alotaibi MR,Neely V,Harada H,Saleh T
MA1-41000 was used in Western Blot to investigate the change in expression of PAMIP1, the gene encoding for the pro-apoptotic protein, NOXA, following NAC in two breast cancer gene datasets, and the change in NOXA protein expression in response to NAC in 55 matched patient samples (pre- and post-NAC).
Sat Sep 23 00:00:00 EDT 2023
PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence.
Cancers
Clairefond S,Péant B,Ouellet V,Barrès V,Tian Z,Trudel D,Karakiewicz PI,Mes-Masson AM,Saad F
MA1-41000 was used in Western Blotting to show that the combination of PUMA and NOXA protein expression in benign epithelial cells was predictive of recurrence following radical prostatectomy and was independent of PSA at diagnosis, Gleason score and pathologic stage.
Thu Oct 29 00:00:00 EDT 2020
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.
Clinical cancer research : an official journal of the American Association for Cancer Research
Lochmann TL,Floros KV,Naseri M,Powell KM,Cook W,March RJ,Stein GT,Greninger P,Maves YK,Saunders LR,Dylla SJ,Costa C,Boikos SA,Leverson JD,Souers AJ,Krystal GW,Harada H,Benes CH,Faber AC
MA1-41000 was used in Western Blotting to identify venetoclax-sensitive small-cell lung cancers and analyse venetoclax's action in these cancers and its anticancer effect.
Mon Jan 15 00:00:00 EST 2018
Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
Biochemical and biophysical research communications
Suzuki J,Nakajima W,Suzuki H,Asano Y,Tanaka N
MA141000 was used in western blot to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer
Sun Jan 22 00:00:00 EST 2017
Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.
Cancer biology & therapy
Nakajima W,Sharma K,Hicks MA,Le N,Brown R,Krystal GW,Harada H
MA141000 was used in western blot to study the effects of HDAC inhibitors and BCL-2 inhibitors on small cell lung cancer lines
Mon Oct 31 00:00:00 EDT 2016
Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Biochemical and biophysical research communications
Matsumoto M,Nakajima W,Seike M,Gemma A,Tanaka N
MA141000 was used in western blot to elucidate the mechanism of cisplatin-induced non-small-cell lung cancer cell apoptosis
Fri Apr 29 00:00:00 EDT 2016
DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex.
Oncotarget
Nakajima W,Sharma K,Lee JY,Maxim NT,Hicks MA,Vu TT,Luu A,Yeudall WA,Tanaka N,Harada H
MA141000 was used in western blot to report that Noxa-mediated MCL-1 phosphorylation and subsequent MCL-1 degradation is critical for DNA damaging agent-induced apoptosis
Tue Jun 14 00:00:00 EDT 2016
Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer.
Cell death & disease
Nakajima W,Hicks MA,Tanaka N,Krystal GW,Harada H
MA1-41000 was used in western blot to evaluate the effect of Noxa on the localization and stability of MCL-1 in small cell lung cancer
Thu Feb 13 00:00:00 EST 2014
BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.
eLife
Vin H,Ojeda SS,Ching G,Leung ML,Chitsazzadeh V,Dwyer DW,Adelmann CH,Restrepo M,Richards KN,Stewart LR,Du L,Ferguson SB,Chakravarti D,Ehrenreiter K,Baccarini M,Ruggieri R,Curry JL,Kim KB,Ciurea AM,Duvic M,Prieto VG,Ullrich SE,Dalby KN,Flores ER,Tsai KY
mA1-41000 was used in western blot to study the role of off-target JNK inhibition in the mechanism by which BRAF inhibitors block apoptosis
Tue Nov 05 00:00:00 EST 2013
Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cells.
PloS one
Pandey MK,Gowda K,Doi K,Sharma AK,Wang HG,Amin S
MA1-41000 was used in western blot to study the effects of the Mcl-1 inhibitor Maritoclax and ABT-737 on melanoma cell survival
Fri Aug 08 00:00:00 EDT 2014